As p21 can also inactivate the KEAP1-NFE2L2 pathway, due to its ability to bind to both of these proteins, one could assume that any increase in its levels might influence the AMD progression via the production of excessive amounts of ROS. Here, NFE2L2 is linked to age-related macular degeneration.